A-770041

Overview

A-770041 is a selective and orally active Src-family Lck inhibitor. A-770041 inhibits Lck with an IC 50 value of 147 nM with the presence of 1 mM ATP. A-770041 shows 300-fold selective to Lck over Fyn , the other Src family kinase involved in T-cell signaling. A-770041 can be used for the research of acute rejection.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Src

Product Information

• Catalog No.: HY-11011
• CAS No.: 869748-10-7
• Molecular Formula: C34H39N9O3
• Molecular Weight: 621.73
• Purity: 99.89%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.08 mg/mL (3.35 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source